Engineering a Therapeutic Protein to Enhance the Study of Anti-Drug Immunity

The development of anti-drug antibodies represents a significant barrier to the utilization of protein-based therapies for a wide variety of diseases. While the rate of antibody formation can vary depending on the therapeutic employed and the target patient population receiving the drug, the antigen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zerra, Patricia E., Parker, Ernest T., Baldwin, Wallace Hunter, Healey, John F., Patel, Seema R., McCoy, James W., Cox, Courtney, Stowell, Sean R., Meeks, Shannon L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313379/
https://www.ncbi.nlm.nih.gov/pubmed/35885029
http://dx.doi.org/10.3390/biomedicines10071724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313379/
https://www.ncbi.nlm.nih.gov/pubmed/35885029
http://dx.doi.org/10.3390/biomedicines10071724

Ejemplares similares